Literature DB >> 2954260

Investigation of the interaction of blood platelets with the coagulation system at the site of plug formation in vivo in man--effect of low-dose aspirin.

P A Kyrle, J Westwick, M F Scully, V V Kakkar, G P Lewis.   

Abstract

In 7 healthy volunteers, formation of thrombin (represented by fibrinopeptide A (FPA) generation, alpha-granule release (represented by beta-thromboglobulin [beta TG] release) and the generation of thromboxane B2 (TxB2) were measured in vivo in blood emerging from a template bleeding time incision. At the site of plug formation, considerable platelet activation and thrombin generation were seen within the first minute, as indicated by a 110-fold, 50-fold and 30-fold increase of FPA, TxB2 and beta TG over the corresponding plasma values. After a further increase of the markers in the subsequent 3 minutes, they reached a plateau during the fourth and fifth minute. A low-dose aspirin regimen (0.42 mg X kg-1 X day-1 for 7 days) caused greater than 90% inhibition of TxB2 formation in both bleeding time blood and clotted blood. At the site of plug formation, alpha-granule release was substantially reduced within the first three minutes and thrombin generation was similarly inhibited. We conclude that (a) marked platelet activation and considerable thrombin generation occur in the early stages of haemostasis, (b) alpha-granule release in vivo is partially dependent upon cyclo-oxygenase-controlled mechanisms and (c) thrombin generation at the site of plug formation is promoted by the activation of platelets.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2954260

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

Review 1.  Coagulation abnormalities and obstetric anaesthesia.

Authors:  M J Douglas
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

2.  Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

Authors:  J C Reverter; S Béguin; H Kessels; R Kumar; H C Hemker; B S Coller
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 3.  Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions.

Authors:  Anetta Undas; Kathleen E Brummel-Ziedins; Kenneth G Mann
Journal:  Blood       Date:  2006-12-05       Impact factor: 22.113

4.  Development of Multifunctional Commercial Pure Titanium-Polyethylene Glycol Drug-Eluting Substrates with Enhanced Optical and Antithrombotic Properties.

Authors:  Monalisha Mohanta; A Thirugnanam
Journal:  Cardiovasc Eng Technol       Date:  2022-06-14       Impact factor: 2.495

Review 5.  The role of serotonin in the preeclampsia-eclampsia syndrome.

Authors:  C P Weiner
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

6.  Studies on the effect of two angiotensin-converting enzyme inhibitors, captopril and cilazapril, on platelet and vascular prostaglandin metabolism in vivo.

Authors:  B Wagner; H G Eichler; B Schneider; B Blöchl-Daum; B Brenner; S Gasic; K Lechner; P A Kyrle
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

7.  The effect of a dual or a triple antithrombotic therapy with apixaban on thrombus formation in vivo and in an ex vivo perfusion chamber model: An open-label, controlled, sequential study.

Authors:  Stefan Weisshaar; Brigitte Litschauer; Sebastian Bucher; Martin Riesenhuber; Stylianos Kapiotis; Paul Alexander Kyrle; Michael Wolzt
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

8.  Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment.

Authors:  Vibeke Bratseth; Alf-Åge Pettersen; Trine B Opstad; Harald Arnesen; Ingebjørg Seljeflot
Journal:  Thromb J       Date:  2012-08-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.